Current Report Filing (8-k)
January 08 2018 - 2:33PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section
13 or 15(d) of
the Securities Exchange Act of 1934
Date of Repor
t (Date of earliest event reported):
January 8, 2018
Nuvectra Corporation
(Exact Name of Registrant as Specified in its Charter)
Delaware
|
001-37525
|
30-0513847
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification Number)
|
5830 Granite Parkway, Suite 1100,
Plano, Texas 75024
(Address of principal executive offices, including zip code)
(
214
)
474
-
3103
(Registrant
’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of th
e registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is
an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company
, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
|
☒
|
Item 2.02
|
Results of Operations and Financial Condition.
|
On
January 8, 2018, Nuvectra Corporation issued a press release regarding its preliminary unaudited fourth quarter and full year 2017 revenue. A copy of the press release is attached hereto as Exhibit 99.1 and is being furnished, not filed, under Item 2.02 of this Current Report on Form 8-K.
Item 8.0
1
|
Other Events
.
|
On January 8, 2018, the Company posted a presentation to its internet website located at
www.nuvectramed.com
that it is utilizing in connection with meetings with certain current and prospective investors, suppliers and customers of the Company (the “Presentation”). A copy of the Presentation is attached hereto as Exhibit 99.2 and is incorporated herein by reference. The Presentation attached as Exhibit 99.2 discloses certain information that is not presented in accordance with United States generally accepted accounting principles (“GAAP”).
Item 9.01
|
Financial Statements and Exhibits.
|
Exhibit No.
|
Description
|
|
|
99.1
|
Press Release dated
January 8, 2018
.
|
99.2
|
Presentation posted to the Nuvectra website on
January 8, 2018.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersign
ed hereunto duly authorized.
|
NUVECTRA CORPORATION
|
|
|
|
|
Date:
January 8, 2018
|
/s/ Walter Z. Berger
|
|
|
Walter Z. Berger
|
|
|
Chief
Operating Officer and Chief Financial Officer
|
|
EXHIBIT INDEX
Nuvectra (NASDAQ:NVTR)
Historical Stock Chart
From May 2024 to Jun 2024
Nuvectra (NASDAQ:NVTR)
Historical Stock Chart
From Jun 2023 to Jun 2024